Vir Biotechnology
Presence
Vir Biotechnology is one of the...
Vir Biotechnology is a company listed under the stock ticker VIR (US).
Executives
View the org chart displaying its 28 main executives
Most searched biographies at Vir Biotechnology
- Marianne De Backer, Chief Executive Officer and Director
- Rob Perez, Director
- Janet Napolitano, Director
Popular executive movements at Vir Biotechnology
- Ramy Farid has joined the company as Director (posted on April 19 2024).
- Norbert Bischofberger has joined the company as Director (posted on April 19 2024).
- Phil Pang, Executive Vice President and Chief Medical Officer, will leave the company on Mar. 1, 2024 (posted on February 21 2024).
Click here to view some more movements at Vir Biotechnology
Create your alert
to follow the executive moves at Vir Biotechnology.
Biotechnology
Vir Biotechnology has 2,297 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Johnson & Johnson has announced the acquisition of Proteologix (posted on May 20 2024).
- Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
Popular contacts in Biotechnology
News
Press releases by Vir Biotechnology
- Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
- Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
- Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
- Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024
- Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
- Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
- Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer
- Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
- Vir Biotechnology, Inc. - Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV
- View more press releases Close
Social media about Vir Biotechnology
- Vir Biotechnology on Wikipedia, Google News & Yahoo Finance
- Vir Biotechnology on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Marianne De Backer 
Call Vir Biotechnology at +1 70...
